Procaps Group S.A. (NASDAQ:PROC) Short Interest Up 56.5% in September

Procaps Group S.A. (NASDAQ:PROC - Get Free Report) was the recipient of a large increase in short interest during the month of September. As of September 15th, there was short interest totalling 18,000 shares, an increase of 56.5% from the August 31st total of 11,500 shares. Currently, 0.1% of the shares of the stock are sold short. Based on an average daily volume of 5,400 shares, the short-interest ratio is currently 3.3 days.

Procaps Group Stock Performance

Shares of PROC traded up $0.07 during mid-day trading on Friday, hitting $2.23. 6,236 shares of the company were exchanged, compared to its average volume of 12,106. Procaps Group has a 1-year low of $1.68 and a 1-year high of $4.95. The company has a 50 day moving average of $2.06 and a 200-day moving average of $2.50. The stock has a market cap of $251.59 million, a price-to-earnings ratio of 4.40 and a beta of 0.15.

About Procaps Group

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.